Applied Therapeutics Inc [APLT] stock is trading at $6.34, up 4.28%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The APLT shares have gain 9.88% over the last week, with a monthly amount glided 12.01%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, RBC Capital Mkts started tracking the stock with Outperform rating on March 26, 2024, and set its price target to $12. On February 22, 2024, Leerink Partners initiated with a Outperform rating and assigned a price target of $12 on the stock. Barclays downgraded its rating to a Equal Weight and decreased its price target to $7 on January 04, 2022. Goldman downgraded its rating to a Sell and reduced its price target to $10 on August 27, 2021. In a note dated October 08, 2020, Truist initiated an Buy rating and provided a target price of $85 on this stock.
Applied Therapeutics Inc [APLT] stock has fluctuated between $1.22 and $9.39 over the past year. Applied Therapeutics Inc [NASDAQ: APLT] shares were valued at $6.34 at the most recent close of the market.
Analyzing the APLT fundamentals
Applied Therapeutics Inc [NASDAQ:APLT] reported sales of 10.66M for the trailing twelve months, which represents a drop of -98.65%. Gross Profit Margin for this corporation currently stands at 3.12% with Operating Profit Margin at 234.34%, Pretax Profit Margin comes in at 483.75%, and Net Profit Margin reading is 483.75%. To continue investigating profitability, this company’s Return on Assets is posted at -1.26, Equity is -5.78 and Total Capital is -1.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.06 points at the first support level, and at 5.78 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.50, and for the 2nd resistance point, it is at 6.66.
Ratios To Look Out For
For context, Applied Therapeutics Inc’s Current Ratio is 2.30. Also, the Quick Ratio is 2.30, while the Cash Ratio stands at 2.21. Considering the valuation of this stock, the price to sales ratio is 68.31, the price to book ratio is 10.06.
Transactions by insiders
Recent insider trading involved Funtleyder Leslie D., Chief Financial Officer, that happened on Aug 22 ’24 when 13530.0 shares were sold. Chief Medical Officer, Perfetti Riccardo completed a deal on Aug 22 ’24 to sell 22681.0 shares. Meanwhile, President and CEO Shendelman Shoshana sold 0.36 million shares on Aug 13 ’24.
